nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—CYP3A4—bone cancer	0.781	1	CbGaD
Epinastine—CYP2B6—Cisplatin—bone cancer	0.054	0.295	CbGbCtD
Epinastine—CYP2B6—Doxorubicin—bone cancer	0.0362	0.198	CbGbCtD
Epinastine—ABCB1—Cisplatin—bone cancer	0.0277	0.151	CbGbCtD
Epinastine—ABCB1—Doxorubicin—bone cancer	0.0186	0.101	CbGbCtD
Epinastine—ABCB1—Methotrexate—bone cancer	0.018	0.0982	CbGbCtD
Epinastine—CYP2D6—Doxorubicin—bone cancer	0.0175	0.0955	CbGbCtD
Epinastine—CYP3A4—Doxorubicin—bone cancer	0.0111	0.0607	CbGbCtD
Epinastine—Oxcarbazepine—CYP3A4—bone cancer	0.000804	0.182	CrCbGaD
Epinastine—Mirtazapine—CYP3A4—bone cancer	0.000687	0.155	CrCbGaD
Epinastine—Carbamazepine—CYP3A4—bone cancer	0.000548	0.124	CrCbGaD
Epinastine—Mianserin—CYP3A4—bone cancer	0.000505	0.114	CrCbGaD
Epinastine—Nortriptyline—CYP3A4—bone cancer	0.000451	0.102	CrCbGaD
Epinastine—Trimipramine—CYP3A4—bone cancer	0.000425	0.0961	CrCbGaD
Epinastine—Desipramine—CYP3A4—bone cancer	0.000371	0.0841	CrCbGaD
Epinastine—Imipramine—CYP3A4—bone cancer	0.000315	0.0713	CrCbGaD
Epinastine—Amitriptyline—CYP3A4—bone cancer	0.000313	0.0709	CrCbGaD
Epinastine—ADRA2A—GPCR ligand binding—GRM4—bone cancer	9.65e-05	0.00302	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—GRM1—bone cancer	9.62e-05	0.00301	CbGpPWpGaD
Epinastine—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	9.58e-05	0.003	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—GRM4—bone cancer	9.36e-05	0.00293	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—RGS1—bone cancer	9.36e-05	0.00293	CbGpPWpGaD
Epinastine—ADRA2A—Platelet activation, signaling and aggregation—GNA11—bone cancer	9.35e-05	0.00293	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	9.34e-05	0.00293	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—GRM1—bone cancer	9.19e-05	0.00288	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—GRM1—bone cancer	9.18e-05	0.00287	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—GRM1—bone cancer	9e-05	0.00282	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—GRM4—bone cancer	8.5e-05	0.00266	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—RGS1—bone cancer	8.5e-05	0.00266	CbGpPWpGaD
Epinastine—ADRA2A—Platelet activation, signaling and aggregation—IL3—bone cancer	8.48e-05	0.00265	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—GRM1—bone cancer	8.37e-05	0.00262	CbGpPWpGaD
Epinastine—CYP2B6—Biological oxidations—GSTP1—bone cancer	8.31e-05	0.0026	CbGpPWpGaD
Epinastine—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	8.19e-05	0.00257	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—GRM1—bone cancer	8.12e-05	0.00254	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	7.95e-05	0.00249	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—GRM1—bone cancer	7.37e-05	0.00231	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	7.24e-05	0.00227	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—GNA11—bone cancer	6.83e-05	0.00214	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—SMO—bone cancer	6.78e-05	0.00212	CbGpPWpGaD
Epinastine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.75e-05	0.00211	CbGpPWpGaD
Epinastine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.66e-05	0.00208	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	6.59e-05	0.00206	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—RGS1—bone cancer	6.55e-05	0.00205	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—GRM4—bone cancer	6.55e-05	0.00205	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	6.5e-05	0.00203	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—SMO—bone cancer	6.48e-05	0.00203	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—SMO—bone cancer	6.46e-05	0.00202	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—SMO—bone cancer	6.34e-05	0.00199	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—JUN—bone cancer	6.27e-05	0.00196	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—NDUFA12—bone cancer	6.21e-05	0.00194	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—GNA11—bone cancer	6.2e-05	0.00194	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—IL3—bone cancer	6.19e-05	0.00194	CbGpPWpGaD
Epinastine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	6.16e-05	0.00193	CbGpPWpGaD
Epinastine—ADRA1A—AMPK Signaling—TP53—bone cancer	6.11e-05	0.00191	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—RGS1—bone cancer	5.99e-05	0.00188	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—GRM4—bone cancer	5.99e-05	0.00188	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—RGS1—bone cancer	5.98e-05	0.00187	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—GRM4—bone cancer	5.98e-05	0.00187	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—SMO—bone cancer	5.89e-05	0.00185	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	5.87e-05	0.00184	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	5.87e-05	0.00184	CbGpPWpGaD
Epinastine—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.83e-05	0.00182	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—NDUFA12—bone cancer	5.82e-05	0.00182	CbGpPWpGaD
Epinastine—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.77e-05	0.00181	CbGpPWpGaD
Epinastine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.69e-05	0.00178	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—GRM1—bone cancer	5.68e-05	0.00178	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—IL3—bone cancer	5.62e-05	0.00176	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	5.51e-05	0.00172	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	5.49e-05	0.00172	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	5.45e-05	0.00171	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	5.45e-05	0.00171	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—RGS1—bone cancer	5.44e-05	0.0017	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—GRM4—bone cancer	5.44e-05	0.0017	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—RGS1—bone cancer	5.43e-05	0.0017	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—GRM4—bone cancer	5.43e-05	0.0017	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—GRM4—bone cancer	5.33e-05	0.00167	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—RGS1—bone cancer	5.33e-05	0.00167	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—SPARC—bone cancer	5.27e-05	0.00165	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—GNA11—bone cancer	5.23e-05	0.00164	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—GRM1—bone cancer	5.2e-05	0.00163	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—SMO—bone cancer	5.19e-05	0.00163	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—GRM1—bone cancer	5.19e-05	0.00162	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—NT5C3A—bone cancer	5.15e-05	0.00161	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	5.09e-05	0.00159	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—GRM4—bone cancer	5.02e-05	0.00157	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—RGS1—bone cancer	5.02e-05	0.00157	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—RGS1—bone cancer	4.95e-05	0.00155	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—GRM4—bone cancer	4.95e-05	0.00155	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—JUN—bone cancer	4.92e-05	0.00154	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—NT5C3A—bone cancer	4.82e-05	0.00151	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—GNA11—bone cancer	4.82e-05	0.00151	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—GNA11—bone cancer	4.75e-05	0.00149	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—IL3—bone cancer	4.74e-05	0.00148	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	4.74e-05	0.00148	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	4.73e-05	0.00148	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—GRM1—bone cancer	4.72e-05	0.00148	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—GRM1—bone cancer	4.71e-05	0.00147	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—GRM1—bone cancer	4.62e-05	0.00145	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—IL3—bone cancer	4.37e-05	0.00137	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—GRM1—bone cancer	4.35e-05	0.00136	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL3—bone cancer	4.31e-05	0.00135	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NDUFA12—bone cancer	4.29e-05	0.00134	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—GRM1—bone cancer	4.29e-05	0.00134	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—TP53—bone cancer	4.14e-05	0.0013	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	4.08e-05	0.00128	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NDUFA12—bone cancer	4.05e-05	0.00127	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—SMO—bone cancer	4e-05	0.00125	CbGpPWpGaD
Epinastine—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.78e-05	0.00118	CbGpPWpGaD
Epinastine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.72e-05	0.00117	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—GNA11—bone cancer	3.66e-05	0.00115	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NT5C3A—bone cancer	3.56e-05	0.00111	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—ATF1—bone cancer	3.4e-05	0.00107	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NT5C3A—bone cancer	3.35e-05	0.00105	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—GNA11—bone cancer	3.35e-05	0.00105	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—GNA11—bone cancer	3.34e-05	0.00105	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—SMO—bone cancer	3.32e-05	0.00104	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL3—bone cancer	3.32e-05	0.00104	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—SMO—bone cancer	3.32e-05	0.00104	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	3.28e-05	0.00103	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—SMO—bone cancer	3.26e-05	0.00102	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—GRM4—bone cancer	3.21e-05	0.00101	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—RGS1—bone cancer	3.21e-05	0.00101	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—GRM4—bone cancer	3.21e-05	0.001	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—RGS1—bone cancer	3.21e-05	0.001	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—RGS1—bone cancer	3.15e-05	0.000986	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—GRM4—bone cancer	3.15e-05	0.000986	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—SMO—bone cancer	3.07e-05	0.00096	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	3.05e-05	0.000954	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—GNA11—bone cancer	3.04e-05	0.000952	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—IL3—bone cancer	3.04e-05	0.00095	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—GNA11—bone cancer	3.03e-05	0.00095	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—IL3—bone cancer	3.03e-05	0.000948	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.03e-05	0.000948	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—SMO—bone cancer	3.02e-05	0.000947	CbGpPWpGaD
Epinastine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	2.99e-05	0.000937	CbGpPWpGaD
Epinastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	2.99e-05	0.000935	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—GNA11—bone cancer	2.98e-05	0.000932	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	2.97e-05	0.000931	CbGpPWpGaD
Epinastine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	2.93e-05	0.000917	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—RGS1—bone cancer	2.92e-05	0.000916	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—GRM4—bone cancer	2.92e-05	0.000916	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	2.92e-05	0.000914	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—PLAU—bone cancer	2.87e-05	0.000897	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TGFBR2—bone cancer	2.84e-05	0.000889	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—GNA11—bone cancer	2.81e-05	0.000878	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—GRM1—bone cancer	2.79e-05	0.000873	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—GRM1—bone cancer	2.78e-05	0.000871	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	2.77e-05	0.000866	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	2.76e-05	0.000865	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL3—bone cancer	2.76e-05	0.000863	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL3—bone cancer	2.75e-05	0.000861	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—GRM1—bone cancer	2.73e-05	0.000854	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL3—bone cancer	2.7e-05	0.000845	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IGF1R—bone cancer	2.67e-05	0.000836	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NDUFA12—bone cancer	2.65e-05	0.000828	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	2.63e-05	0.000824	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—ATF1—bone cancer	2.61e-05	0.000817	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL3—bone cancer	2.54e-05	0.000796	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—GRM1—bone cancer	2.54e-05	0.000794	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL3—bone cancer	2.51e-05	0.000785	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ENO2—bone cancer	2.25e-05	0.000706	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NT5C3A—bone cancer	2.19e-05	0.000686	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TGFBR2—bone cancer	2.18e-05	0.000681	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ENO2—bone cancer	2.11e-05	0.000662	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—DHFR—bone cancer	2.09e-05	0.000655	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.07e-05	0.000648	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IGF1R—bone cancer	2.05e-05	0.000641	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SMO—bone cancer	1.96e-05	0.000615	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—DHFR—bone cancer	1.96e-05	0.000614	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SMO—bone cancer	1.96e-05	0.000614	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—GNA11—bone cancer	1.95e-05	0.000612	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—KIT—bone cancer	1.94e-05	0.000607	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SMO—bone cancer	1.92e-05	0.000602	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—GNA11—bone cancer	1.83e-05	0.000574	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—BRAF—bone cancer	1.82e-05	0.00057	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—GNA11—bone cancer	1.8e-05	0.000562	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—GNA11—bone cancer	1.79e-05	0.000561	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SMO—bone cancer	1.79e-05	0.000559	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—CYP3A4—bone cancer	1.77e-05	0.000555	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—EGFR—bone cancer	1.77e-05	0.000553	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—GNA11—bone cancer	1.76e-05	0.000551	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.74e-05	0.000544	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ATF1—bone cancer	1.67e-05	0.000523	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ATF1—bone cancer	1.67e-05	0.000522	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—CYP3A4—bone cancer	1.66e-05	0.00052	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ATF1—bone cancer	1.64e-05	0.000512	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—GNA11—bone cancer	1.63e-05	0.000512	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL3—bone cancer	1.63e-05	0.00051	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL3—bone cancer	1.62e-05	0.000509	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL3—bone cancer	1.59e-05	0.000499	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ENO2—bone cancer	1.56e-05	0.000488	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MDM2—bone cancer	1.53e-05	0.000478	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ATF1—bone cancer	1.52e-05	0.000476	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—GSTP1—bone cancer	1.52e-05	0.000474	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—KIT—bone cancer	1.48e-05	0.000465	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL3—bone cancer	1.48e-05	0.000464	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ENO2—bone cancer	1.47e-05	0.00046	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—DHFR—bone cancer	1.45e-05	0.000453	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—GSTP1—bone cancer	1.42e-05	0.000445	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—BRAF—bone cancer	1.4e-05	0.000437	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TGFBR2—bone cancer	1.39e-05	0.000436	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TGFBR2—bone cancer	1.39e-05	0.000435	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	1.36e-05	0.000427	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—DHFR—bone cancer	1.36e-05	0.000427	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—EGFR—bone cancer	1.35e-05	0.000423	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GNA11—bone cancer	1.35e-05	0.000423	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—JUN—bone cancer	1.33e-05	0.000415	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IGF1R—bone cancer	1.31e-05	0.00041	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IGF1R—bone cancer	1.31e-05	0.000409	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MMP9—bone cancer	1.29e-05	0.000404	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	1.28e-05	0.000402	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GNA11—bone cancer	1.27e-05	0.000399	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	1.27e-05	0.000397	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CYP3A4—bone cancer	1.23e-05	0.000384	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	1.19e-05	0.000373	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MDM2—bone cancer	1.17e-05	0.000366	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CYP3A4—bone cancer	1.15e-05	0.000361	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—TP53—bone cancer	1.15e-05	0.000361	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTP1—bone cancer	1.05e-05	0.000328	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EGFR—bone cancer	1.04e-05	0.000326	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—JUN—bone cancer	1.02e-05	0.000318	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MMP9—bone cancer	9.89e-06	0.00031	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTP1—bone cancer	9.87e-06	0.000309	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ENO2—bone cancer	9.6e-06	0.000301	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—KIT—bone cancer	9.5e-06	0.000298	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—KIT—bone cancer	9.48e-06	0.000297	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—KIT—bone cancer	9.31e-06	0.000291	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—BRAF—bone cancer	8.93e-06	0.00028	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—BRAF—bone cancer	8.91e-06	0.000279	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—DHFR—bone cancer	8.91e-06	0.000279	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—bone cancer	8.76e-06	0.000274	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—BRAF—bone cancer	8.75e-06	0.000274	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—bone cancer	8.66e-06	0.000271	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—KIT—bone cancer	8.65e-06	0.000271	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—bone cancer	8.64e-06	0.00027	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	8.48e-06	0.000265	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GNA11—bone cancer	8.33e-06	0.000261	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—BRAF—bone cancer	8.13e-06	0.000254	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—bone cancer	7.99e-06	0.00025	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	7.88e-06	0.000247	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—bone cancer	7.85e-06	0.000246	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MDM2—bone cancer	7.48e-06	0.000234	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MDM2—bone cancer	7.47e-06	0.000234	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—bone cancer	7.36e-06	0.00023	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MDM2—bone cancer	7.33e-06	0.000229	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MDM2—bone cancer	6.81e-06	0.000213	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—bone cancer	6.71e-06	0.00021	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—JUN—bone cancer	6.51e-06	0.000204	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—JUN—bone cancer	6.49e-06	0.000203	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTP1—bone cancer	6.46e-06	0.000202	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—JUN—bone cancer	6.37e-06	0.000199	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—bone cancer	6.33e-06	0.000198	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—bone cancer	6.32e-06	0.000198	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—bone cancer	6.2e-06	0.000194	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—JUN—bone cancer	5.92e-06	0.000185	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—bone cancer	5.76e-06	0.00018	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—bone cancer	5.43e-06	0.00017	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—bone cancer	5.12e-06	0.00016	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—bone cancer	5.11e-06	0.00016	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—bone cancer	5.1e-06	0.00016	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—bone cancer	5.01e-06	0.000157	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—bone cancer	4.65e-06	0.000146	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—bone cancer	4.29e-06	0.000134	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—bone cancer	4.29e-06	0.000134	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—bone cancer	4.21e-06	0.000132	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—bone cancer	3.91e-06	0.000122	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—bone cancer	3.34e-06	0.000105	CbGpPWpGaD
